Abstract
Pro-inflammatory cytokine IL-17A modulates the expression of Akt in bleomycin (BLM) administered alveolar basal epithelial cells, the mechanism behind which remains unclear. This investigation was carried out to assess IL-17A mediated down-regulation of Akt expression and the pivotal role of curcumin as a regulatory molecule. Alveolar basal epithelial cells were treated with BLM and IL-17A and curcumin was administered as an intervention to regulate the BLM-induced oxidative damage. Cell proliferation was evaluated by clonogenic assay. Akt phosphorylation and total Akt expressions were studied using western blot analysis. Cell proliferation reduced upon treatment with BLM and this phenomenon was reversed in cells upon administration with curcumin. Administrations of BLM and IL-17A to the alveolar basal epithelial cells showed significant down-regulation of Akt expression which was reversed by treatment with curcumin. BLM and IL-17A mediated inflammation was intervened effectively with curcumin. Results of this study suggest the probable use of curcumin as an anti-inflammatory therapeutic for lung injury.
References
Matthay MA, Zimmerman GA, Esmon C, Bhattacharya J, Coller B, Doerschuk CM et al (2003) Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Res Crit Care Med 167(7):1027–1035
Grommes J, Soehnlein O (2011) Contribution of neutrophils to acute lung injury. Mol Med 17(3–4):293
McElroy MC, Kasper M (2004) The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair. Eur Respir J 24(4):664–673
Williamson JD, Sadofsky LR, Hart SP (2015) The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis. Exp Lung Res 41(2):57–73
Wilson MS, Madala SK, Ramalingam TR, Gochuico BR, Rosas IO, Cheever AW et al (2010) Bleomycin and IL-1β-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med 207(3):535–552
Gasse P, Riteau N, Vacher R, Michel ML, Fautrel A, Di Padova F et al (2011) IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis. PLoS ONE 6(8):e23185
Wei X, Han J, Chen ZZ, Qi BW, Wang GC, Ma YH et al (2010) A phosphoinositide 3-kinase-γ inhibitor, AS605240 prevents bleomycin-induced pulmonary fibrosis in rats. Biochem Biophys Res Commun 397(2):311–317
Bhandary YP, Shetty SK, Marudamuthu AS, Ji HL, Neuenschwander PF, Boggaram V et al (2013) Regulation of lung injury and fibrosis by p53-mediated changes in urokinase and plasminogen activator inhibitor-1. Am J Pathol 183(1):131–143
Aggarwal BB, Harikumar KB (2009) Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 41(1):40–59
Zhang Y, Liang D, Dong L, Ge X, Xu F, Chen W et al (2015) Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury. Resp Res 16(1):43
Venkatesan N, Punithavathi V, Chandrakasan G (1997) Curcumin protects bleomycin-induced lung injury in rats. Life Sci 61(6):A51-A58
Lee VY, Schroedl C, Brunelle JK, Buccellato LJ, Akinci OI, Kaneto H et al (2005) Bleomycin induces alveolar epithelial cell death through JNK-dependent activation of the mitochondrial death pathway. Am J Physiol Lung Cell Mol Physiol 289(4):L521–L528
Martin TR, Hagimoto N, Nakamura M, Matute-Bello G (2005) Apoptosis and epithelial injury in the lungs. Proc Am Thorac Soc 2(3):214–220
Smith MR, Gangireddy SR, Narala VR, Hogaboam CM, Standiford TJ, Christensen PJ et al (2010) Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury. Am J Physiol Lung Cell Mol Physiol 298(5):L616–L625
Liu Y (2015) Type II cells as progenitors in alveolar repair, lung stem cells in the epithelium and vasculature. Stem Cell Biol Regen Med. https://doi.org/10.1007/978-3-319-16232-4$42
Kshirsagar S, Riedl M, Billing H, Tönshoff B, Thangavadivel S, Steuber C et al (2014) AKT-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis. J Immunol 193(10):4895–4903
Lu Y, Parkyn L, Otterbein LE, Kureishi Y, Walsh K, Ray A et al (2001) Activated Akt protects the lung from oxidant-induced injury and delays death of mice. J Exp Med 193(4):545–550
Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96(6):857–868
Wang A, Wang J, Zhang H, Zhang S, Xu Z, Li X (2017) Curcumin inhibits the development of non-small cell lung cancer by inhibiting autophagy and apoptosis. Exp Ther Med 14(5):5075–5080
Gouda MM, Bhandary YP (2018) Curcumin down-regulates IL-17A mediated p53-fibrinolytic system in bleomycin induced acute lung injury in vivo. J Cell Biochem. https://doi.org/10.1002/jcb.27026
Acknowledgements
Authors would like to acknowledge the financial support rendered by Yenepoya University.
Funding
This work is supported by funding support from Indian Council of Medical Research (Grant No: 2015-1235) and research grants from Yenepoya University.
Author information
Authors and Affiliations
Contributions
Conceived the idea and designed the experiments: YPB. Performed the experiments: MMG, AP. Data analysis and representation: MMG, AP.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This is an in vitro study using immortalized cell lines. Ethical clearance is not applicable.
Additional information
Mahesh Manjunath Gouda and Ashwini Prabhu are equal first authors.
Rights and permissions
About this article
Cite this article
Gouda, M.M., Prabhu, A. & Bhandary, Y.P. IL-17A suppresses and curcumin up-regulates Akt expression upon bleomycin exposure. Mol Biol Rep 45, 645–650 (2018). https://doi.org/10.1007/s11033-018-4199-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-018-4199-3